Roche Launches COVID-19 Test For Cobas System; BioMérieux Plans Three COVID-19 Tests
Roche announced that the US FDA has granted an Emergency Use Authorization for the cobas SARS-CoV-2 test for patients suspected to have COVID-19. bioMérieux is planning three COVID-19 tests.
You may also be interested in...
Widespread implementation of rapid diagnostic tests is critical for decreasing antimicrobial resistance.
Roche's diagnostics division grew 3% in the first half of 2020 with exploding demand for COVID-19 tests offsetting declines in routine testing.
Roche's diagnostics sales increased 5% to $2.93bn in the first quarter of 2020. Molecular diagnostics was the main growth contributor, driven by demand for COVID-19 tests and automated testing systems.